SEC Form 4 · accession 0001140361-15-003825
SALIX PHARMACEUTICALS LTD · SLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William C Bertrand Jr.
Officer — See Remarks
Period of report
Jan 31, 2015
Accepted (ET)
Feb 3, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001009356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2015 | A | 2,851 | $0.00 | A | 31,258 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award which will vest annually in two equal installments on February 1, 2016 and February 1, 2017, subject to continued employment.
Remarks
Senior Vice President, General Counsel and Acting Chief Operating Officer